From: Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism
 | HrEF (n = 190) | HFmrEF (n = 259) | nornal EF (n = 4323) | p value |
---|---|---|---|---|
Age | 63.76 ± 10.33 | 64.03 ± 11.25 | 63.09 ± 10.67 | ns |
Sex (Female%) | 43.15 | 42.93 | 42.06 | ns |
EF (%) | 33.20 ± 5.74 | 45.76 ± 2.77 | 67.09 ± 5.94 | p < 0.001 |
LVEDD (mm) | 65.56 ± 8.46 | 57.85 ± 6.19 | 49.23 ± 4.09 | p < 0.001 |
LVESD (mm) | 54.67 ± 8.31 | 46.05 ± 3.89 | 30.59 ± 3.96 | p < 0.001 |
UA (umol/L) | 402.87 ± 131.12 | 364.39 ± 123.03 | 325.08 ± 86.72 | p < 0.001 |
AST (U/L) | 30.56 ± 34.23 | 30.50 ± 34.90 | 25.42 ± 39.01 | ns |
ALT (U/L) | 33.97 ± 48.55 | 36.88 ± 37.41 | 29.65 ± 27.44 | ns |
Cre (μmol/L) | 97.12 ± 112.65 | 87.58 ± 73.19 | 66.53 ± 32.30 | p < 0.001 |
Chol (mmol/L) | 3.56 ± 0.88 | 3.60 ± 0.91 | 3.88 ± 1.10 | ns |
TG (mmol/L) | 3.24 ± 1.15 | 3.43 ± 1.09 | 3.54 ± 1.39 | ns |
HDL-C (mmol/L) | 0.93 ± 0.23 | 0.94 ± 0.21 | 1.06 ± 0.29 | ns |
LDL-C (mmol/L) | 2.17 ± 0.90 | 2.17 ± 0.31 | 2.21 ± 0.87 | ns |
HbA1C (%) | 6.40 ± 1.31 | 6.50 ± 1.48 | 6.04 ± 1.10 | p < 0.001 |